Ardelyx (ARDX) Assets Average (2014 - 2026)
Ardelyx (ARDX) reported Assets Average of $503.1 million for Q1 2026, up 18.93% on a YoY basis from $423.0 million in Q1 2025, and up 1.86% quarter-over-quarter from $493.9 million in Q4 2025.
Ardelyx (ARDX) Assets Average (2014 - 2026) Analysis & Trends
Ardelyx has reported Assets Average for 13 years, with the latest figure at $503.1 million in Q1 2026.
- For the quarter ending Q1 2026, Assets Average rose 18.93% year-over-year to $503.1 million; the trailing twelve-month figure through Mar 2026 stood at $503.1 million (up 18.93% YoY), and the FY2025 full-year result was $468.7 million, up 27.82% from the prior year.
- Assets Average for Q1 2026 stood at $503.1 million, up from $493.9 million in the prior quarter.
- The five-year high for Assets Average was $503.1 million in Q1 2026, with the low at $130.5 million in Q2 2022.
- Historically, Assets Average has averaged $311.3 million across 5 years, with a median of $320.0 million in 2024.
- Annual changes were most pronounced in 2022 — Assets Average slumped 37.15% — and 2023, when it jumped 81.19%.
- Ardelyx's Assets Average stood at $167.4 million in 2022, then surged by 75.35% to $293.5 million in 2023, then soared by 36.91% to $401.8 million in 2024, then increased by 22.92% to $493.9 million in 2025, then advanced by 1.86% to $503.1 million in 2026.
- The last three Assets Average figures came in at $503.1 million (Q1 2026), $493.9 million (Q4 2025), and $476.5 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 33.42 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 795.91 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 13.04 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 1.72 Bn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 26.03 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 40.89 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 10.06 Mn |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 26.06 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 660.38 Mn |
| 10 | Ardelyx | 1.49 Bn | 1.25 Bn | 89.66 Mn | 503.06 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 503.06 Mn |
| Dec 31, 2025 | 493.89 Mn |
| Sep 30, 2025 | 476.47 Mn |
| Jun 30, 2025 | 438.48 Mn |
| Mar 31, 2025 | 422.97 Mn |
| Dec 31, 2024 | 401.81 Mn |
| Sep 30, 2024 | 355.68 Mn |
| Jun 30, 2024 | 342.94 Mn |
| Mar 31, 2024 | 319.98 Mn |
| Dec 31, 2023 | 293.48 Mn |
| Sep 30, 2023 | 250.29 Mn |
| Jun 30, 2023 | 214.11 Mn |
| Mar 31, 2023 | 203.54 Mn |
| Dec 31, 2022 | 167.37 Mn |
| Sep 30, 2022 | 138.14 Mn |
| Jun 30, 2022 | 130.51 Mn |
| Mar 31, 2022 | 139.66 Mn |
| Dec 31, 2021 | 160.38 Mn |
| Sep 30, 2021 | 187.92 Mn |
| Jun 30, 2021 | 207.64 Mn |